Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer

Brachytherapy

Volumn 4, Issue 3, 2005, Pages 202-206

  Hsu, I Chow J ^a,b   Cabrera, Alvin R ^a   Weinberg, Vivian ^b   Speight, Joycelyn ^a   Gottschalk, Alexander R ^a   Roach III, Mack ^a   Shinohara, Katsuto ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brachytherapy; HDR; Prostate cancer; Radiotherapy

Indexed keywords

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HUMAN; IMPLANT; MALE; MULTIMODALITY CANCER THERAPY; PELVIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; RISK FACTOR; SMALL INTESTINE OBSTRUCTION; SURGICAL TECHNIQUE; SURVIVAL RATE; TIME; TOXICITY; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE;

AGED; BRACHYTHERAPY; COMORBIDITY; DISEASE-FREE SURVIVAL; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 25144478766     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2005.03.005     Document Type: Article

References (24)

1. M.A. Bagshaw, R.S. Cox, and G.R. Ray Status of radiation treatment of prostate cancer at Stanford University NCI Monogr 7 1988 47 60
2. C.A. Perez, M.V. Pilepich, and F. Zivnuska Tumor control in definitive irradiation of localized carcinoma of the prostate Int J Radiat Oncol Biol Phys 12 1986 523 531
3. G.E. Hanks, J.J. Diamond, and J.M. Krall A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States Int J Radiat Oncol Biol Phys 13 1987 499 505
4. G.K. Zagars, A.C. von Eschenbach, and D.E. Johnson Stage C adenocarcinoma of the prostate: An analysis of 551 patients treated with external beam irradiation Cancer 60 1987 1489 1499
5. M.J. Zelefsky, Z. Fuks, and L. Happersett Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Radiother Oncol 55 2000 241 249
6. M.V. Pilepich, K. Winter, and M.J. John Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 2001 1243 1252
7. E.M. Horwitz, K. Winter, and G.E. Hanks Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy Int J Radiat Oncol Biol Phys 49 2001 947 956
8. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial Lancet 360 2002 103 106
9. G.E. Hanks, T.F. Pajak, and A. Porter Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02 J Clin Oncol 21 2003 3972 3978
10. M. Roach 3rd, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
11. R.M. Galalae, G. Kovacs, and J. Schultze Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90
12. A. Martinez, J. Gonzalez, and W. Spencer Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors J Urol 169 2003 974 979 (discussion: 979-980)
13. M. Roach 3rd, C. Marquez, and H.S. Yuo Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer (see comments) Int J Radiat Oncol Biol Phys 28 1994 33 37
14. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel Int J Radiat Oncol Biol Phys 37 1997 1035 1041
15. G. Borghede, H. Hedelin, and S. Holmäng Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland Radiother Oncol 44 1997 245 250
16. A. Martinez, J. Gonzalez, and J. Stromberg Conformal prostate brachytherapy: Initial experience of a phase I/II dose-escalating trial Int J Radiat Oncol Biol Phys 33 1995 1019 1027
17. T.P. Mate, J.E. Gottesman, and J. Hatton High dose-rate afterloading 192Iridium prostate brachytherapy: Feasibility report Int J Radiat Oncol Biol Phys 41 1998 525 533
18. J. Demanes, R.R. Rodriguez, and G.A. Altieri High dose rate prostate brachytherapy: The California Endocurietherapy (CET) Method Radiother Oncol 57 2000 289 296
19. B. Lachance, D. Beliveau-Nadeau, and E. Lessard Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate Int J Radiat Oncol Biol Phys 54 2002 86 100
20. J.F. Fowler, R.J. Chappell, and M.A. Ritter The prospects for new treatments for prostate cancer Int J Radiat Oncol Biol Phys 52 2002 3 5
21. D. Brenner, A.A. Martinez, and G.K. Edmundson Direct evidence that prostate tumors show high sensitivity to fractionation (low a/b ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
22. I.-C. Hsu, B. Pickett, and K. Shinohara Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation Int J Radiat Oncol Biol Phys 46 2000 851 858
23. A.A. Martinez, G. Gustafson, and J. Gonzalez Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 53 2002 316 327
24. A. Martinez, R. Galalae, and J. Gonzalez No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose J Urol 170 2003 2296 2301